Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis

Acta Neuropathologica

Volumn 107, Issue 2, 2004, Pages 137-143

  Kawamoto, Yasuhiro ^a   Akiguchi, Ichiro ^a   Kovácz, Gábor G ^b   Flicker, Helga ^b   Budka, Herbert ^b  

^a KYOTO UNIVERSITY   (Japan)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

14 3 3 proteins; Glial cells; Immunohistochemistry; Multiple sclerosis; Progressive multifocal leukoencephalopathy

Indexed keywords

BIOCHEMICAL MARKER; FORMALDEHYDE; PARAFFIN; PROTEIN 14 3 3; PROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE PROJECTION; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN LOCALIZATION; TISSUE FIXATION; UPREGULATION;

14-3-3 PROTEINS; ADULT; AGED; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROGLIA; TYROSINE 3-MONOOXYGENASE;

EID: 0742289654     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-003-0785-z     Document Type: Article

References (37)

1. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/ p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153:801-813
2. Aquino DA, Capello E, Weisstein J, Sanders V, Lopez C, Tourtellotte WW, Brosnan CF, Raine CS, Norton WT (1997) Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. J Neuropathol Exp Neurol 56:664-672
3. Bonetti B, Raine CS (1997) Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42:74-84
4. Boston PF, Jackson P, Kynoch PAM, Thompson RJ (1982) Purification, properties, and immunohistochemical localisation of human brain 14-3-3 protein. J Neurochem 38:1466-1474
5. Boston PF, Jackson P, Thompson RJ (1982) Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 38:1475-1482
6. Brosnan CF, Battistini L, Gao Y-L, Raine CS, Aquino DA (1996) Heat shock proteins and multiple sclerosis: a review. J Neuropathol Exp Neurol 55:389-402
7. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Jou P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
8. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719
9. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241
10. NTR neurotrophin receptor on glial cells in MS plaques. Neurology 53:1676-1682
11. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617-647
12. Hernández Echebarría LE, Saiz A, Graus F, Tejada J, Gracía JM, Clavera B, Fernández F (2000) Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. Neurology 54:1539-1540
13. Hisahara S, Shoji S, Okano H, Miura M (1997) ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 69:10-20
14. Hsich G, Kenney K, Gibbs CJ Jr, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924-930
15. Ichijo H, Nishida E, Irie K, Dijke P ten, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94
16. Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355: 901
17. Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 61:245-253
18. Kawamoto Y, Akiguchi I, Nakamura S, Budka H (2002) Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 52:722-731
19. Kimura MT, Irie S, Shoji-Hoshino S, Mukai J, Nadano D, Oshimura M, Sato T-A (2001) 14-3-3 is involved in p75 neurotrophin receptor-mediated signal transduction. J Biol Chem 276:17291-17300
20. Klemenz R, Fröhli E, Steiger RH, Schäfer R, Aoyama A (1991) αB-Crystallin is a small heat shock protein. Proc Natl Acad Sci USA 88:3652-3656
21. Komori T, Ishizawa K, Arai N, Hirose T, Mizutani T, Oda M (2003) Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol 106:66-70
22. Laudiero LB, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen S, Otten U (1992) Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 147:9-12
23. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett 209:57-60
24. Martínez-Yélamos A, Saiz A, Sanchez-Valle R, Casado V, Ramón JM, Graus F, Arbizu T (2001) 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology 57:722-724
25. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Noort S van den, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
26. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
27. Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RHC, Cuzner ML, Polman CH, Uitdehaag BMJ, Thompson EJ, Giovannoni G (2002) Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 125:1462-1473
28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
29. Prabhakar S, Kurien E, Gupta RS, Zielinski S, Freedman MS (1994) Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology 44:1644-1648
30. Prineas JW, McDonald WI (1997) Demyelinating diseases. In: Graham DI, Lantos PL (eds) Greenfield's neuropathology, 6th edn, vol 1. Arnold, London, pp 813-896
31. Saiz A, Graus F, Dalmau J, Pifarré A, Marín C, Tolosa E (1999) Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 46:774-777
32. Sharief MK, Hentges R (199 1) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 325:467-472
33. Sharp FR, Massa SM, Swanson RA (1999) Heat-shock protein protection. Trends Neurosci 22:97-99
34. Takano R, Hisahara S, Namikawa K, Kiyama H, Okano H, Miura M (2000) Nerve growth factor protects oligodendrocytes from tumor necrosis factor-α-induced injury through Akt-mediated signaling mechanisms. J Biol Chem 275:16360-16365
35. Van Noort JM, Sechel AC van, Bajramovic JJ, Ouagmiri MEI, Polman CH, Lassmann H, Ravid R (1995) The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798-801
36. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32-40
37. Zhang L, Chen J, Fu H (1999) Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 96:8511-8515